Equities

Auxly Cannabis Group Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Auxly Cannabis Group Inc

Actions
  • Price (EUR)0.0738
  • Today's Change-0.006 / -7.75%
  • Shares traded11.00k
  • 1 Year change+158.04%
  • Beta1.4206
Data delayed at least 15 minutes, as of Feb 06 2026 07:10 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Auxly Cannabis Group Inc. is a Canadian consumer packaged goods company in the cannabis products market. Its brands include Foray, Kolab Project, Back Forty, Dosecann, and Parcel. Foray is a versatile, modern, and inviting cannabis brand, designed for the curious. Kolab Project offers a refined collection of cannabis products and design-focused, purposeful goods. The Company also engages in wholesale bulk cannabis transactions with various licensed producers in Canada. Its subsidiaries are Auxly Charlottetown Inc., Auxly Ottawa Inc. and Auxly Leamington Inc. Its primary Cannabis 2.0 Product development, manufacturing and R&D activities are conducted by its subsidiary Auxly Charlottetown Inc. at a cannabis processing facility located in Charlottetown, Prince Edward Island. Auxly Ottawa Inc. holds licenses for cultivation and processing under the cannabis act and conducts the Company’s primary dried flower and pre-roll manufacturing.

  • Revenue in CAD (TTM)146.00m
  • Net income in CAD45.34m
  • Incorporated1987
  • Employees388.00
  • Location
    Auxly Cannabis Group Inc777 Richmond St. W, Unit 002TORONTO M6J 0C2CanadaCAN
  • Phone+1 (647) 812-0121
  • Fax+1 (416) 863-1716
  • Websitehttps://www.auxly.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.